NIH-funded research R01 grant

Using lung CT scans to spot COPDearly and help people

Official title: Leveraging Quantitative Imaging from Lung Cancer Screening to Create Tools to Confront COPD

Funded at University of Michigan at Ann Arbor · NIH-11400493 · Data updated 2026-11-12

A researcher team will use data from lung cancer screening CT scans to improve COPD screening and help people at risk get diagnosed sooner.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Michigan at Ann Arbor
NIH-funded
Lab location1 site (Ann Arbor, United States)
Project startSeptember 1, 2024
Project endJuly 31, 2028
Funding year2026
Award (this year)$656,948
NIH project number5R01HL174648-03
Project IDNIH-11400493 on NIH RePORTER

Who could benefit from this research

Could help

Adults aged 50–80 with a ≥20 pack-year smoking history who are undergoing LDCT lung cancer screening.

Less likely to help

Patients not demonstrating COPD risk on imaging or not undergoing LDCT screening may not benefit from this tool.

What this research studies

This project plans to analyze low-dose CT scan data from lung cancer screening to identify imaging features that signal COPD in individuals aged 50–80 with a significant smoking history. By combining quantitative lung measurements with existing screening results, it aims to create a practical tool for clinicians to flag high-risk patients who should undergo pulmonary function testing. The study leverages data already collected in routine screenings and translates it into a COPD screening aid that could be integrated into care pathways. Participants would not need to undergo additional invasive procedures beyond standard screening data analysis.

Why it matters

Potential benefit: If successful, patients at risk could receive earlier COPD detection and timely treatment, potentially reducing complications and mortality.

How similar studies have gone: Prior work has shown that quantitative emphysema features on LDCT can help identify COPD, with broader adoption of imaging-based risk markers still pending.

Where this research is happening

  • University of Michigan at Ann Arbor
    Ann Arbor, United States
    Active

Researchers

  • Principal investigator: Han, Meilan K — University of Michigan at Ann Arbor
  • Study coordinator: Han, Meilan K

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.